- Home
- GANX vs RFIL Comparison
GANX vs RFIL Comparison
Compare GANX & RFIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GANX
- RFIL
- Stock Information
- Founded
- GANX 2017
- RFIL 1979
- Country
- GANX United States
- RFIL United States
- Employees
- GANX N/A
- RFIL N/A
- Industry
- GANX Biotechnology: Pharmaceutical Preparations
- RFIL Electrical Products
- Sector
- GANX Health Care
- RFIL Technology
- Exchange
- GANX Nasdaq
- RFIL Nasdaq
- Market Cap
- GANX 41.9M
- RFIL 42.4M
- IPO Year
- GANX 2021
- RFIL N/A
- Fundamental
- Price
- GANX $1.58
- RFIL $3.75
- Analyst Decision
- GANX Strong Buy
- RFIL Strong Buy
- Analyst Count
- GANX 5
- RFIL 1
- Target Price
- GANX $7.60
- RFIL $4.50
- AVG Volume (30 Days)
- GANX 203.8K
- RFIL 8.6K
- Earning Date
- GANX 11-14-2024
- RFIL 01-21-2025
- Dividend Yield
- GANX N/A
- RFIL N/A
- EPS Growth
- GANX N/A
- RFIL N/A
- EPS
- GANX N/A
- RFIL N/A
- Revenue
- GANX N/A
- RFIL $62,278,000.00
- Revenue This Year
- GANX N/A
- RFIL N/A
- Revenue Next Year
- GANX N/A
- RFIL $8.38
- P/E Ratio
- GANX N/A
- RFIL N/A
- Revenue Growth
- GANX N/A
- RFIL N/A
- 52 Week Low
- GANX $0.89
- RFIL $2.61
- 52 Week High
- GANX $5.33
- RFIL $4.65
- Technical
- Relative Strength Index (RSI)
- GANX 42.64
- RFIL 34.00
- Support Level
- GANX $1.59
- RFIL $4.07
- Resistance Level
- GANX $1.70
- RFIL $4.39
- Average True Range (ATR)
- GANX 0.15
- RFIL 0.16
- MACD
- GANX 0.00
- RFIL -0.04
- Stochastic Oscillator
- GANX 19.74
- RFIL 0.00
About GANX Gain Therapeutics Inc.
Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across, several therapeutics areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. The company's clinical-stage product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson's disease. The company uses its computational target and drug discovery platform, Magellan, to discover novel allosteric binding sites on proteins implicated in disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. The company derives revenues from collaboration and licensing agreements.
About RFIL RF Industries Ltd.
RF Industries Ltd is engaged in the design, manufacture, and marketing of interconnect products and systems, including coaxial and specialty cables, fiber optic cables and connectors, and electrical and electronic specialty cables. The company operates through two segments: RF Connector and Cable Assembly, which consists of the Connector and Cable Assembly Division, and Custom Cabling Manufacturing and Assembly, which consists of its subsidiaries. The company has operations in the United States, Canada, Israel, and Mexico.